ZAUATBAYEVA, G. .; SYZDYKOVA , L.; KEYER , V. .; SHUSTOV , A.; ABILMAGZHANOV , A.; ZHURYNOV , M. NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS. Eurasian Journal of Applied Biotechnology, [S. l.], n. 2, p. 44–53, 2022. DOI: 10.11134/btp.2.2022.7. Disponível em: https://biotechlink.org/index.php/journal/article/view/338. Acesso em: 5 oct. 2022.